Biopharmaceuticals
Biopharmaceutical companies have been facing turbulent times, grappling with financing uncertainty, heightened M&A activity, and increased scrutiny on pipeline developments and program stages. However, amidst these challenges, the demand for strong leadership remains robust. Now more than ever, companies require seasoned, strategic executives equipped with the insights and perspectives to navigate this complexity.
Each of our Partners brings over 30 years of invaluable relationships and networks within the biopharma industry. At Chartwell Partners, we collaborate closely with our clients to recruit exceptional management teams and Boards of Directors. Together, we strive to ensure that our clients are equipped with the talent and expertise necessary to thrive in today's dynamic, yet challenging, landscape.
Our results are industry leading and reflect our hands-on, Partner led approach:
• Average days to search completion – 85
• Placement retention rate – 96%
• 87% repeat clients
• Over 55% diversity recruitments
Our Team
Hanna Im-Lee
BIOPHARMACEUTICALS
Overview
Our team is focused on the recruitment of Board Members, CEOs and executive leaders across all major functional disciplines, including commercial, finance, corporate development, human resources, R&D, medical, regulatory and technical operations. Our clients are innovative emerging and established therapeutics companies leading the way towards the discovery, development and commercialization of cutting-edge medicines to treat critically ill patients. We work with organizations at every stage of corporate formation and evolution: from startup through commercialization, private to public, and across all therapeutic areas and modalities.
Stealth Mode Companies
We partner with companies at their earliest stages of development to build out leadership teams, expanding upon the expertise of the original scientific founders, and adding competencies throughout the entire C-level. We understand how to attract seasoned industry leaders to complement the scientific luminaries who form this sector’s most exciting companies.
Private to Public
As our clients prepare for their IPOs, we engage with them regarding Board and management team evolution, always with an emphasis on creating and fostering greater diversity in knowledge, perspective, experience and background.
R&D to Commercial
We are retained when companies are planning to grow beyond a purely R&D focus into a fully integrated, commercial enterprise. We have demonstrated expertise identifying executives who will successfully lead through this transition, develop increased organizational capabilities and scale, and help to create a collaborative, cross functional, efficient and culturally aligned team.
Investors
We work with today’s leading venture, family office and private equity investors to build their biopharma portfolio companies and bring transformative science from the laboratory to patients.
News
BIOPHARMACEUTICALS
Neurogene Inc. Announces Appointment of Julie Jordan, M.D., as Chief Medical Officer
BIOPHARMACEUTICALS
Ambrx Appoints Renu Vaish, M.Sc., as Chief Regulatory Officer to Lead Regulatory Affairs